The relationship between COMT, proline, and negative symptoms in clinical high risk and recent psychosis onset
Translational Psychiatry · 2024
DOI: 10.1038/s41398-024-03099-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Psychiatry, 2024. Verfasst von James D Clelland und 6 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Department, The Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY, USA. Hauptthemen laut MEDLINE: Catechol O-Methyltransferase, Proline, Psychotic Disorders. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIMH NIH HHS, NCATS NIH HHS, U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH).
Abstract (Originalsprache)
Individuals at clinical high-risk (CHR) of developing psychosis, as well as patients with recent psychosis onset (RO), experience significant negative symptoms that detrimentally impact daily-life functioning and are associated with poor outcomes, even in those who do not convert to psychosis. Targeting negative symptoms may thus hold promise for the treatment of CHR and RO patients. Building from previous findings we examined whether the catechol-O-methyltransferase (COMT) Val158Met functional polymorphism and fasting peripheral proline concentration predicts the severity of negative symptoms experienced by adolescents and young adults at CHR or those with RO. As hypothesized, the interaction between fasting plasma proline and COMT predicted negative symptoms, as measured via the Scale for the Assessment of Negative Symptoms (SANS) total (n = 50, β = 0.066, adjusted p = 0.007) and global severity scores (n = 50, coefficient = 0.026, adjusted p = 0.003): Higher proline was beneficial for Val/Val subjects, but detrimental to those with the Met allele. In a secondary analysis, the COMT x proline interaction also predicted symptoms measured via the Clinical Assessment Interview for Negative Symptoms (CAINS) total scores (n = 50, β-coefficient = 0.035, adjusted p = 0.044), although this result did not reach the Benjamini-Hochberg's threshold for significance. Further, there was a trend towards significance for an association with social and interpersonal function (Global Functioning-Social, coefficient = -0.005, adjusted p = 0.055). Negative symptoms are intractable and largely unaddressed by current medications. This study further supports a relationship between peripheral proline and COMT influencing negative symptoms such as anhedonia, in young CHR individuals and those with RO. That higher proline has converse effects on symptoms by COMT may have implications for the development of therapeutics to intervene early and specifically target the interaction pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Clinical Research Department, The Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY, USA.
- Department of Psychiatry, Columbia University Irving Medical Center, New York, NY, USA.
- The Center of Prevention and Evaluation, New York State Psychiatric Institute, New York, NY, USA.
- New York State Office of Mental Health, Rockland Psychiatric Center, Orangeburg, NY, USA.
- Department of Psychiatry, Columbia University Irving Medical Center, New York, NY, USA. cc2786@cumc.columbia.edu.
- Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Irving Medical Center, New York, NY, USA. cc2786@cumc.columbia.edu.
ORCID-Profile: Catherine L Clelland
Förderung
- NIMH NIH HHS
- NCATS NIH HHS
- U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH)
Zitieren
APA
Clelland, J. D., Hesson, H., Ramiah, K., Anderson, J., Thengampallil, A., Girgis, R. R., & Clelland, C. L. (2024). The relationship between COMT, proline, and negative symptoms in clinical high risk and recent psychosis onset. Translational Psychiatry. https://doi.org/10.1038/s41398-024-03099-0
Vancouver
Clelland JD, Hesson H, Ramiah K, Anderson J, Thengampallil A, Girgis RR, et al. The relationship between COMT, proline, and negative symptoms in clinical high risk and recent psychosis onset. Translational Psychiatry. 2024. doi:10.1038/s41398-024-03099-0
BibTeX
@article{Clelland2024,
author = {Clelland, James D and Hesson, Hannah and Ramiah, Krista and Anderson, Julia and Thengampallil, Abraham and Girgis, Ragy R and Clelland, Catherine L},
title = {The relationship between COMT, proline, and negative symptoms in clinical high risk and recent psychosis onset},
journal = {Translational Psychiatry},
year = {2024},
doi = {10.1038/s41398-024-03099-0}
}
EUVIMED